Search Results - "Rigat, F"

Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study by Lohrmann, Florens, Hufnagel, Markus, Kunze, Mirjam, Afshar, Baharak, Creti, Roberta, Detcheva, Antoaneta, Kozakova, Jana, Rodriguez-Granger, Javier, Sørensen, Uffe B. Skov, Margarit, Immaculada, Maione, Domenico, Rinaudo, Daniela, Orefici, Graziella, Telford, John, de la Rosa Fraile, Manuel, Kilian, Mogens, Efstratiou, Androulla, Berner, Reinhard, Melin, Pierrette

“…Purpose Group B streptococcus (GBS) remains a leading cause of invasive disease, mainly sepsis and meningitis, in infants < 3 months of age and of mortality…”
Get full text

Parallel hierarchical sampling: A general-purpose interacting Markov chains Monte Carlo algorithm by Rigat, F., Mira, A.

“…A novel class of interacting Markov chain Monte Carlo (MCMC) algorithms, hereby referred to as the Parallel Hierarchical Sampler (PHS), is developed and its…”
Get full text

Conjugation of a TLR7 agonist and antigen enhances protection in the S. pneumoniae murine infection model by Vecchi, S., Bufali, S., Uno, T., Wu, T., Arcidiacono, L., Filippini, S., Rigat, F., O’Hagan, D.

“…[Display omitted] Next generation vaccine adjuvants include Toll like receptor agonists, which are mostly extracted from microorganisms, but synthetic small…”
Get full text

Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage by Frosi, Giacomo, Biolchi, Alessia, Sapio, Morena Lo, Rigat, Fabio, Gilchrist, Stefanie, Lucidarme, Jay, Findlow, Jamie, Borrow, Ray, Pizza, Mariagrazia, Giuliani, Marzia Monica, Medini, Duccio

“…Highlights • All MenB disease isolates from England and Wales, 2007–2008, were analyzed in MATS. • Stratified proportional sampling identified a representative…”
Get full text

Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI study by Lohrmann, Florens, Efstratiou, Androulla, Sørensen, Uffe B Skov, Creti, Roberta, Decheva, Antoaneta, Křížová, Pavla, Kozáková, Jana, Rodriguez-Granger, Javier, De La Rosa Fraile, Manuel, Margarit, Immaculada, Rinaudo, Daniela, Maione, Domenico, Telford, John, Orefici, Graziella, Kilian, Mogens, Afshar, Baharak, Melin, Pierrette, Berner, Reinhard, Hufnagel, Markus, Kunze, Mirjam

“…Despite national guidelines and use of intrapartum antibiotic prophylaxis (IAP), Streptococcus agalactiae (group B streptococci (GBS)) is still a leading cause…”
Get full text

11P Pharmacokinetic/pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study by Angevin, E., Groenland, S., Bauer, T., Rischin, D., Gardeazabal, I., Moreno, V., Trigo, J.M., Chisamore, M., Shaik, J., Rigat, F., Ellis, C., Chen, H., Gagnon, R., Scherer, S.J., Turner, D., Yadavilli, S., Ballas, M., Hoos, A., Maio, M.

Get full text

Pharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study by Maio, M., Groenland, S.L., Bauer, T., Rischin, D., Gardeazabal, I., Moreno, V., Trigo Perez, J.M., Chisamore, M., Sadik Shaik, J., Rigat, F., Ellis, C., Chen, H., Gagnon, R., Scherer, S., Turner, D., Yadavilli, S., Ballas, M., Hoos, A., Angevin, E.

Get full text

1971P - Pharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study by Maio, M., Groenland, S.L., Bauer, T., Rischin, D., Gardeazabal, I., Moreno, V., Trigo Perez, J.M., Chisamore, M., Sadik Shaik, J., Rigat, F., Ellis, C., Chen, H., Gagnon, R., Scherer, S., Turner, D., Yadavilli, S., Ballas, M., Hoos, A., Angevin, E.

“…GSK609 an agonist non-T cell depleting IgG4 monoclonal antibody (mAb) against inducible co-stimulatory receptor (ICOS) exhibits T cell mediated immune…”
Get full text

1971PPharmacokinetic/ pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study by Maio, M, Groenland, S L, Bauer, T, Rischin, D, Gardeazabal, I, Moreno, V, Trigo Perez, J M, Chisamore, M, Sadik Shaik, J, Rigat, F, Ellis, C, Chen, H, Gagnon, R, Scherer, S, Turner, D, Yadavilli, S, Ballas, M, Hoos, A, Angevin, E

“…Abstract Background GSK609 an agonist non-T cell depleting IgG4 monoclonal antibody (mAb) against inducible co-stimulatory receptor (ICOS) exhibits T cell…”
Get full text

Gene Expression Phenotypes of Atherosclerosis by Seo, David, Wang, Tao, Dressman, Holly, Herderick, Edward E, Iversen, Edwin S, Dong, Chunming, Vata, Korkut, Milano, Carmelo A, Rigat, Fabio, Pittman, Jennifer, Nevins, Joseph R, West, Mike, Goldschmidt-Clermont, Pascal J

“…OBJECTIVE—Fulfilling the promise of personalized medicine by developing individualized diagnostic and therapeutic strategies for atherosclerosis will depend on…”
Get full text

PS1372 B‐CELL MATURATION ANTIGEN ANTIBODY‐DRUG CONJUGATE (ADC), GSK2857916, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL SAFETY, EFFICACY AND PHARMACOKINETIC (PK) ANALYSES FROM A PHASE I STUDY by Popat, R., Lendvai, N., Trudel, S., Voorhees, P.M., Reeves, B., Libby, E.N., Richardson, P.G., Jr, L.D. Anderson, Sutherland, H.J., Yong, K., Hoos, A., Gorczyca, M.M., He, Z., Jewell, R.C., Dettman, E.J., Rigat, F., Gupta, I., Bragulat, V., Opalinska, J.B., Cohen, A.D.

“…Please indicate where the has been published before: A portion of these data have been submitted for publication in Blood Cancer Journal, of which interim data…”
Get full text